Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
Authors:
- Michele M. CastroMCMichele M. Castro
- Elen RizziERElen Rizzi
- Gerson J. RodriguesGRGerson J. Rodrigues
- Carla S. CeronCCCarla S. Ceron
- Jose E. Tanus-SantosJTJose E. Tanus-Santos
- 1 May 2009
- journal article
- research article
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 46 (9) , 1298-1307
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Bioavailability of apocynin through its conversion to glycoconjugate but not to diapocyninPhytomedicine, 2008
- Apocynin Is Not an Inhibitor of Vascular NADPH Oxidases but an AntioxidantHypertension, 2008
- Acute actions and novel targets of matrix metalloproteinases in the heart and vasculatureBritish Journal of Pharmacology, 2007
- Vascular remodeling and protease inhibition—bench to bedsideCardiovascular Research, 2006
- Aldosterone Stimulates Matrix Metalloproteinases and Reactive Oxygen Species in Adult Rat Ventricular CardiomyocytesHypertension, 2005
- Angiotensin II induces MMP-2 in a p47phox-dependent mannerBiochemical and Biophysical Research Communications, 2005
- Reactive Oxygen Species, Vascular Oxidative Stress, and Redox Signaling in HypertensionHypertension, 2004
- Homocysteine induced impairment of nitric oxide-dependent vasorelaxation is reversible by the superoxide dismutase mimetic TEMPOLNephrology Dialysis Transplantation, 2004
- Oxidative Stress in Arterial HypertensionHypertension, 2001